| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.21 | 9e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.25 | 5e-05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |